Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756530 | SCV000884365 | likely pathogenic | not provided | 2018-06-20 | criteria provided, single submitter | clinical testing | The PKD1 c.3145_3156del12; p.Val1049_Ala1052del variant, to our knowledge, is not described in the medical literature or in gene-specific database. It is also absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant deletes 4 amino acid residues leaving the rest of the protein in-frame. Other in-frame deletions in this region (c.3137_3154del; p.Asp1046_Val1051del, c.3122_3124del; p.Ala1041del) have been described in individuals with autosomal dominant polycystic kidney disease and are considered pathogenic (Carrera 2016, Neumann 2013). Based on available information, this variant is considered likely pathogenic. References: Carrera P et al. Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Sci Rep. 2016 Aug 8;6:30850. Neumann H et al. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant. 2013 Jun;28(6):1472-87. |